Chapter 25 : Impact of Conjugate Pneumococcal Vaccine on Antibiotic Resistance

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Impact of Conjugate Pneumococcal Vaccine on Antibiotic Resistance, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815820/9781555814083_Chap25-1.gif /docserver/preview/fulltext/10.1128/9781555815820/9781555814083_Chap25-2.gif


The fact that vaccinating infants and young children reduced drug-resistant (DRSP) disease and the carriage of pediatric DRSP serotypes in adults serves as the most compelling and definitive proof that children are responsible in a large part for the transmission of DRSP in the community. In a study to find out the efficacy of the conjugate pneumococcal vaccine against pneumococcal invasive disease caused by DRSP, 19,922 infants received pneumococcal conjugate vaccine (PCV) 9 and 19,914 received a placebo. Another study conducted by the Centers for Disease Control and Prevention (CDC), used laboratory-based active surveillance in multiple representative areas in the United States (the Active Bacterial Core Surveillance) to measure invasive diseases caused by DRSP from 1996 through 2004. The study by Byington and coworkers suggests that invasive pneumococcal infections with nonvaccine serotypes that are nonsusceptible to penicillin are increasing. The changes in proportions of pathogens isolated in cases of severe and refractory AOM before (1992 to 1998) and after (2000 to 2003) the introduction of universal vaccination in rural Kentucky were documented. The proportion of isolates decreased from 160 of 336 (48%) to 26 of 83 (31%) and the proportion of isolates increased from 137 of 336 (41%) to 46 of 83 (56%). Since antibiotic use selects for and promotes antibiotic resistance among strains, an important question is whether the use of PCVs can reduce antibiotic use.

Citation: Dagan R, Klugman K. 2008. Impact of Conjugate Pneumococcal Vaccine on Antibiotic Resistance, p 369-385. In Siber G, Klugman K, Mäkelä P (ed), Pneumococcal Vaccines. ASM Press, Washington, DC. doi: 10.1128/9781555815820.ch25
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

Pulsed-field gel electrophoresis fingerprint patterns and dendrogram of SmaI restriction digests of representative isolates of 26 Pneumococcal Molecular Epidemiology Network clones. Reprinted from http://www.sph.emory.edu/PMEN/pmen_clone_collection.html with permission. (Courtesy Leslie McGee, Emory University.)

Citation: Dagan R, Klugman K. 2008. Impact of Conjugate Pneumococcal Vaccine on Antibiotic Resistance, p 369-385. In Siber G, Klugman K, Mäkelä P (ed), Pneumococcal Vaccines. ASM Press, Washington, DC. doi: 10.1128/9781555815820.ch25
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Adrian, P. V., and, K. P. Klugman. 1997. Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41: 24062413.
2. Arason, V. A.,, K. G. Kristinsson,, J. A. Sigurdsson,, G. Stefansdottir,, S. Molstad, and, S. Gudmundsson. 1996. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 313: 387391.
3. Arnold, S. R., and, A. J. Bush. 2006. Decline in inappropriate antibiotic use over a decade by pediatricians in a Tennessee community. Ambul. Pediatr. 6: 225229.
4. Beall, B.,, M. C. McEllistrem,, R. E. Gertz, Jr.,, S. Wedel,, D. J. Boxrud,, A. L. Gonzalez,, M. J. Medina,, R. Pai,, T. A. Thompson,, L. H. Harrison,, L. McGee, and, C. G. Whitney. 2006. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J. Clin. Microbiol. 44: 9991017.
5. Bedos, J. P.,, S. Chevret,, C. Chastang,, P. Geslin, and, B. Regnier. 1996. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey. Clin. Infect. Dis. 22: 6372.
6. Black, S.,, H. Shinefield,, R. Baxter,, R. Austrian,, L. Bracken,, J. Hansen,, E. Lewis, and, B. Fireman. 2004. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr. Infect. Dis. J. 23: 485489.
7. Black, S.,, H. Shinefield,, B. Fireman,, E. Lewis,, P. Ray,, J. R. Hansen,, L. Elvin,, K. M. Ensor,, J. Hackell,, G. Siber,, F. Malinoski,, D. Madore,, I. Chang,, R. Kohberger,, W. Watson,, R. Austrian, and, K. Edwards. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19: 187195.
8. Block, S. L.,, J. Hedrick,, C. J. Harrison,, R. Tyler,, A. Smith,, R. Findlay, and, E. Keegan. 2004. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr. Infect. Dis. J. 23: 829833.
9. Brandileone, M. C.,, S. T. Casagrande,, M. L. Guerra,, R. C. Zanella,, A. L. Andrade, and, J. L. Di Fabio. 2006. Increase in numbers of beta-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage. J. Med. Microbiol. 55: 567574.
10. Breiman, R. F.,, J. C. Butler,, F. C. Tenover,, J. A. Elliott, and, R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271: 18311835.
11. Bronzwaer, S. L.,, O. Cars,, U. Buchholz,, S. Molstad,, W. Goettsch,, I. K. Veldhuijzen,, J. L. Kool,, M. J. Sprenger, and, J. E. Degener. 2002. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. 8: 278282.
12. Buie, K. A.,, K. P. Klugman,, A. von Gottberg,, O. Perovic,, A. Karstaedt,, H. H. Crewe-Brown,, S. A. Madhi, and, C. Feldman. 2004. Gender as a risk factor for both antibiotic resistance and infection with pediatric serogroups/serotypes, in HIV-infected and -uninfected adults with pneumococcal bacteremia. J. Infect. Dis. 189: 19962000.
13. Byington, C. L.,, M. H. Samore,, G. J. Stoddard,, S. Barlow,, J. Daly,, K. Korgenski,, S. Firth,, D. Glover,, J. Jensen,, E. O. Mason,, C. K. Shutt, and, A. T. Pavia. 2005. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin. Infect. Dis. 41: 2129.
14. Casey, J. R., and, M. E. Pichichero. 2004. Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr. Infect. Dis. J. 23: 824828.
15. Centers for Disease Control and Prevention. 2002. Epidemiology and Prevention of Vaccine-Preventable Disease, 7th ed., p. 257270. Public Health Foundation, Washington, D.C. www.cdc.gov/nip/publications/pinkl.
16. Chen, D. K.,, A. McGeer,, J. C. de Azavedo,, D. E. Low, and the Canadian Bacterial Surveillance Network. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341: 233239.
17. Cohen, R.,, C. Levy,, F. de La Rocque,, N. Gelbert,, A. Wollner,, B. Fritzell,, E. Bonnet,, R. Tetelboum, and, E. Varon. 2006. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr. Infect. Dis. J. 25: 10011007.
18. Cutts, F. T.,, S. M. Zaman,, G. Enwere,, S. Jaffar,, O. S. Levine,, J. B. Okoko,, C. Oluwalana,, A. Vaughan,, S. K. Obaro,, A. Leach,, K. P. McAdam,, E. Biney,, M. Saaka,, U. Onwuchekwa,, F. Yallop,, N. F. Pierce,, B. M. Greenwood, and, R. A. Adegbola. 2005. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365: 11391146.
19. Dagan, R.,, N. Givon-Lavi,, D. Fraser,, M. Lipsitch,, G. R. Siber, and, R. Kohberger. 2005. Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J. Infect. Dis. 192: 367376.
20. Dagan, R.,, N. Givon-Lavi,, L. Shkolnik,, P. Yagupsky, and, D. Fraser. 2000. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines. J. Infect. Dis. 181: 13221329.
21. Dagan, R.,, N. Givon-Lavi,, O. Zamir, and, D. Fraser. 2003. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day care centers. Pediatr. Infect. Dis. J. 22: 532539.
22. Dagan, R.,, N. Givon-Lavi,, O. Zamir,, M. Sikuler-Cohen,, L. Guy,, J. Janco,, P. Yagupsky, and, D. Fraser. 2002. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J. Infect. Dis. 185: 927936.
23. Dagan, R.,, R. Melamed,, M. Muallem,, L. Piglansky,, D. Greenberg,, O. Abramson,, P. M. Mendelman,, N. Bohidar, and, P. Yagupsky. 1996. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J. Infect. Dis. 174: 12711278.
24. Dagan, R.,, M. Muallem,, R. Melamed,, O. Leroy, and, P. Yagupsky. 1997. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr. Infect. Dis. J. 16: 10601064.
25. Dagan, R.,, M. Sikuler-Cohen,, O. Zamir,, J. Janco,, N. Givon-Lavi, and, D. Fraser. 2001. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr. Infect. Dis. J. 20: 951958.
26. Dagan, R.,, O. Zamir,, N. Tirosh,, I. Belmaker,, L. Guy,, D. Greenberg, and, D. Fraser. 2000. Nasopharyngeal carriage of Streptococcus pneumoniae in toddlers vaccinated during infancy with an 11-valent pneumococcal vaccine conjugated to diphtheria and tetanus toxoids, abstr. 236. 40th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
27. Davies, T. A.,, K. Bush,, D. Sahm, and, A. Evangelista. 2005. Predominance of 23S rRNA mutants among non-Erm, non-Mef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999–2000. Antimicrob. Agents Chemother. 49: 30313033.
28. De Lencastre, H.,, K. G. Kristinsson,, A. Brito-Avo,, I. S. Sanches,, R. Sa-Leao,, J. Saldanha,, E. Sigvaldadottir,, S. Karlsson,, D. Oliveira,, R. Mato,, M. Aires de Sousa, and, A. Tomasz. 1999. Carriage of respiratory tract pathogens and molecular epidemiology of Streptococcus pneumoniae colonization in healthy children attending day care centers in Lisbon, Portugal. Microb. Drug Resist. 5: 1929.
29. Del Grosso, M.,, F. Iannelli,, C. Messina,, M. Santagati,, N. Petrosillo,, S. Stefani,, G. Pozzi, and, A. Pantosti. 2002. Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40: 774778.
30. Dias, R., and, M. Canica. 2004. Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14. J. Antimicrob. Chemother. 54: 10351039.
31. Eskola, J.,, T. Kilpi,, A. Palmu,, J. Jokinen,, J. Haapakoski,, E. Herva,, A. Takala,, H. Kayhty,, P. Karma,, R. Kohberger,, G. Siber, and, P. H. Makela. 2001. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344: 403409.
32. Farrell, D. J.,, K. P. Klugman, and, M. Pichichero. 2007. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr. Infect. Dis. J. 26: 123128.
33. Feikin, D. R.,, K. P. Klugman,, R. R. Facklam,, E. R. Zell,, A. Schuchat, and, C. G. Whitney. 2005. Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin. Infect. Dis. 41: 481487.
34. Finkelstein, J. A.,, C. Stille,, J. Nordin,, R. Davis,, M. A. Raebel,, D. Roblin,, A. S. Go,, D. Smith,, C. C. Johnson,, K. Kleinman,, K. A. Chan, and, R. Platt. 2003. Reduction in antibiotic use among US children, 1996–2000. Pediatrics 112: 620627.
35. Fireman, B.,, S. B. Black,, H. R. Shinefield,, J. Lee,, E. Lewis, and, P. Ray. 2003. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr. Infect. Dis. J. 22: 1016.
36. Flannery, B.,, R. T. Heffernan,, L. H. Harrison,, S. M. Ray,, A. L. Reingold,, J. Hadler,, W. Schaffner,, R. Lynfield,, A. R. Thomas,, J. Li,, M. Campsmith,, C. G. Whitney, and, A. Schuchat. 2006. Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann. Intern. Med. 144: 19.
37. Frazao, N.,, A. Brito-Avo,, C. Simas,, J. Saldanha,, R. Mato,, S. Nunes,, N. G. Sousa,, J. A. Carrico,, J. S. Almeida,, I. Santos-Sanches, and, H. de Lencastre. 2005. Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon. Pediatr. Infect. Dis. J. 24: 243252.
38. Gabriel, M. E.,, L. Aiuto,, N. Kohn, and, S. R. Barone. 2004. Management of febrile children in the conjugate pneumococcal vaccine era. Clin. Pediatr. (Philadelphia) 43: 7582.
39. Gherardi, G.,, C. G. Whitney,, R. R. Facklam, and, B. Beall. 2000. Major related sets of antibiotic-resistant pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J. Infect. Dis. 181: 216229.
40. Givon-Lavi, N.,, R. Dagan,, D. Fraser,, P. Yagupsky, and, N. Porat. 1999. Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area. Clin. Infect. Dis. 29: 12741280.
41. Givon-Lavi, N.,, D. Fraser, and, R. Dagan. 2003. Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings. Pediatr. Infect. Dis. J. 22: 524531.
42. Givon-Lavi, N.,, D. Fraser,, N. Porat, and, R. Dagan. 2002. Spread of Streptococcus pneumoniae and antibiotic-resistant S. pneumoniae from day-care center attendees to their younger siblings. J. Infect. Dis. 186: 16081614.
43. Goossens, H.,, M. Ferech,, R. Vander Stichele, and, M. Elseviers. 2005. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365: 579587.
44. Halasa, N. B.,, M. R. Griffin,, Y. Zhu, and, K. M. Edwards. 2002. Decreased number of antibiotic prescriptions in office-based settings from 1993 to 1999 in children less than five years of age. Pediatr. Infect. Dis. J. 21: 10231028.
45. Hammitt, L. L.,, D. L. Bruden,, J. C. Butler,, H. C. Baggett,, D. A. Hurlburt,, A. Reasonover, and, T. W. Hennessy. 2006. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J. Infect. Dis. 193: 14871494.
46. Hanage, W. P.,, S. S. Huang,, M. Lipsitch,, C. J. Bishop,, D. Godoy,, S. I. Pelton,, R. Goldstein,, H. Huot, and, J. A. Finkelstein. 2007. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J. Infect. Dis. 195: 347352.
47. Hansman, D., and, M. Bullen. 1967. A resistant pneumococcus. Lancet ii: 264265.
48. Harbarth, S.,, W. Albrich, and, C. Brun-Buisson. 2002. Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a socio-cultural perspective. Emerg. Infect. Dis. 8: 14601467.
49. Hendley, J. O.,, M. A. Sande,, P. M. Stewart, and, J. M. Gwaltney, Jr. 1975. Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J. Infect. Dis. 132: 5561.
50. Hennessy, T. W.,, R. J. Singleton,, L. R. Bulkow,, D. L. Bruden,, D. A. Hurlburt,, D. Parks,, M. Moore,, A. J. Parkinson,, A. Schuchat, and, J. C. Butler. 2005. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. Vaccine 23: 54645473.
51. Ho, P. L.,, W. S. Tse,, K. W. Tsang,, T. K. Kwok,, T. K. Ng,, V. C. Cheng, and, R. M. Chan. 2001. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin. Infect. Dis. 32: 701707.
52. Hogberg, L.,, P. Geli,, H. Ringberg,, E. Melander,, M. Lipsitch, and, K. Ekdahl. 2007. Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci. J. Clin. Microbiol. 45: 948952.
53. Huang, S. S.,, J. A. Finkelstein, and, M. Lipsitch. 2005. Modeling community- and individual-level effects of child care attendance on pneumococcal carriage. Clin. Infect. Dis. 40: 12151222.
54. Huang, S. S.,, R. Platt,, S. L. Rifas-Shiman,, S. I. Pelton,, D. Goldmann, and, J. A. Finkelstein. 2005. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116: e408e413.
55. Jacobs, M. R.,, D. Felmingham,, P. C. Appelbaum, and, R. N. Gruneberg. 2003. The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J. Antimicrob. Chemother. 52: 229246.
56. Jacobs, M. R.,, H. J. Koornhof,, R. M. Robins-Browne,, C. M. Stevenson,, Z. A. Vermaak,, I. Freiman,, G. B. Miller,, M. A. Witcomb,, M. Isaacson,, J. I. Ward, and, R. Austrian. 1978. Emergence of multiply resistant pneumococci. N. Engl. J. Med. 299: 735740.
57. Jokinen, J.,, H. Ahman,, T. Kilpi,, P. H. Makela, and, H. Kayhty. 2004. Concentration of anti-pneumococcal antibodies as a serological correlate of protection: an application to acute otitis media. J. Infect. Dis. 190: 545550.
58. Joloba, M. L.,, A. Windau,, S. Bajaksouzian,, P. C. Appelbaum,, W. P. Hausdorff, and, M. R. Jacobs. 2001. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clin. Infect. Dis. 33: 14891494.
59. Kaplan, S. L.,, E. O. Mason, Jr.,, E. R. Wald,, G. E. Schutze,, J. S. Bradley,, T. Q. Tan,, J. A. Hoffman,, L. B. Givner,, R. Yogev, and, W. J. Barson. 2004. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113: 443449.
60. Kayhty, H.,, K. Auranen,, H. Nohynek,, R. Dagan, and, H. Makela. 2006. Nasopharyngeal colonization: a target for pneumococcal vaccination. Expert Rev. Vaccines 5: 651668.
61. Kellner, J. D.,, E. L. Ford-Jones, and the Toronto Child Care Centre Study Group. 1999. Streptococcus pneumoniae carriage in children attending 59 Canadian child care centers. Arch. Pediatr. Adolesc. Med. 158: 495502.
62. Kilpi, T.,, H. Ahman,, J. Jokinen,, K. S. Lankinen,, A. Palmu,, H. Savolainen,, M. Gronholm,, M. Leinonen,, T. Hovi,, J. Eskola,, H. Kayhty,, N. Bohidar,, J. C. Sadoff, and, P. H. Makela. 2003. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin. Infect. Dis. 37: 11551164.
63. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3: 171196.
64. Klugman, K. P.,, S. A. Madhi,, R. E. Huebner,, R. Kohberger,, N. Mbelle, and, N. Pierce. 2003. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N. Engl. J. Med. 349: 13411348.
65. Kyaw, M. H.,, R. Lynfield,, W. Schaffner,, A. S. Craig,, J. Hadler,, A. Reingold,, A. R. Thomas,, L. H. Harrison,, N. M. Bennett,, M. M. Farley,, R. R. Facklam,, J. H. Jorgensen,, J. Besser,, E. R. Zell,, A. Schuchat, and, C. G. Whitney. 2006. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354: 14551463.
66. Lipsitch, M. 2001. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin. Infect. Dis. 32: 10441054.
67. Lopez, P.,, M. Espinosa,, B. Greenberg, and, S. A. Lacks. 1987. Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydro-pteroate synthase and characterization of the enzyme. J. Bacteriol. 169: 43204326.
68. Malhotra-Kumar, S.,, C. Lammens,, S. Coenen,, K. Van Herck, and, H. Goossens. 2007. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 369: 482490.
69. Mbelle, N.,, R. E. Huebner,, A. D. Wasas,, A. Kimura,, I. Chang, and, K. P. Klugman. 1999. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J. Infect. Dis. 180: 11711176.
70. McEllistrem, M. C.,, J. Adams,, E. O. Mason, and, E. R. Wald. 2003. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J. Infect. Dis. 188: 16791684.
71. McEllistrem, M. C.,, J. M. Adams,, K. Patel,, A. B. Mendelsohn,, S. L. Kaplan,, J. S. Bradley,, G. E. Schutze,, K. S. Kim,, E. O. Mason, and, E. R. Wald. 2005. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin. Infect. Dis. 40: 17381744.
72. McGee, L.,, L. McDougal,, J. Zhou,, B. G. Spratt,, F. C. Tenover,, R. George,, R. Hakenbeck,, W. Hryniewicz,, J. C. Lefevre,, A. Tomasz, and, K. P. Klugman. 2001. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39: 25652571.
73. Moore, M. R.,, T. B. Hyde,, T. W. Hennessy,, D. J. Parks,, A. L. Reasonover,, M. Harker-Jones,, J. Gove,, D. L. Bruden,, K. Rudolph,, A. Parkinson,, J. C. Butler, and, A. Schuchat. 2004. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J. Infect. Dis. 190: 20312038.
74. O'Brien, K. L., and, R. Dagan. 2003. The potential indirect effect of conjugate pneumococcal vaccines. Vaccine 21: 18151825.
75. O'Brien, K. L.,, L. H. Moulton,, R. Reid,, R. Weatherholtz,, J. Oski,, L. Brown,, G. Kumar,, A. Parkinson,, D. Hu,, J. Hackell,, I. Chang,, R. Kohberger,, G. Siber, and, M. Santosham. 2003. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet 362: 355361.
76. Pai, R.,, M. R. Moore,, T. Pilishvili,, R. E. Gertz,, C. G. Whitney, and, B. Beall. 2005. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J. Infect. Dis. 192: 19881995.
77. Perz, J. F.,, A. S. Craig,, C. S. Coffey,, D. M. Jorgensen,, E. Mitchel,, S. Hall,, W. Schaffner, and, M. R. Griffin. 2002. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA 287: 31033109.
78. Porat, N.,, A. Arguedas,, B. G. Spratt,, R. Trefler,, E. Brilla,, C. Loaiza,, D. Godoy,, N. Bilek, and, R. Dagan. 2004. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J. Infect. Dis. 190: 21542161.
79. Porat, N.,, G. Barkai,, M. R. Jacobs,, R. Trefler, and, R. Dagan. 2004. Four antibiotic resistant S. pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel. J. Infect. Dis. 189: 385392.
80. Radetsky, M. S.,, G. R. Istre,, T. L. Johansen,, S. W. Parmelee,, B. A. Lauer,, A. M. Wiesenthal, and, M. P. Glode. 1981. Multiply resistant pneumococcus causing meningitis: its epidemiology within a day-care centre. Lancet ii: 771773.
81. Regelmann, W. E. 2005. A pain in the ear: what has the 7-valent conjugated pneumococcal vaccine done to reduce the incidence of acute otitis media? Clin. Infect. Dis. 40: 17451747.
82. Regev-Yochay, G.,, M. Raz,, B. Shainberg,, R. Dagan,, M. Varon,, M. Dushenat, and, E. Rubinstein. 2003. Independent risk factors for carriage of penicillin-non-susceptible Streptococcus pneumoniae. Scand. J. Infect. Dis. 35: 219222.
83. Reichler, M. R.,, A. A. Allphin,, R. F. Breiman,, J. R. Schreiber,, J. E. Arnold,, L. K. McDougal,, R. R. Facklam,, B. Boxerbaum,, D. May,, R. O. Walton, et al. 1992. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J. Infect. Dis. 166: 13461353.
84. Song, J. H.,, S. I. Jung,, K. S. Ko,, N. Y. Kim,, J. S. Son,, H. H. Chang,, H. K. Ki,, W. S. Oh,, J. Y. Suh,, K. R. Peck,, N. Y. Lee,, Y. Yang,, Q. Lu,, A. Chongthaleong,, C. H. Chiu,, M. K. Lalitha,, J. Perera,, T. T. Yee,, G. Kumarasinghe,, F. Jamal,, A. Kamarulzaman,, N. Parasakthi,, P. H. Van,, C. Carlos,, T. So,, T. K. Ng, and, A. Shibl. 2004. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob. Agents Chemother. 48: 21012107.
85. Spratt, B. G., and, B. M. Greenwood. 2000. Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet 356: 12101211.
86. Steenhoff, A. P.,, S. S. Shah,, A. J. Ratner,, S. M. Patil, and, K. L. McGowan. 2006. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clin. Infect. Dis. 42: 907914.
87. Stephens, D. S.,, S. M. Zughaier,, C. G. Whitney,, W. S. Baughman,, L. Barker,, K. Gay,, D. Jackson,, W. A. Orenstein,, K. Arnold,, A. Schuchat, and, M. M. Farley. 2005. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 365: 855863.
88. Stoll, M. L., and, L. G. Rubin. 2004. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center. Arch. Pediatr. Adolesc. Med. 158: 671675.
89. Syrogiannopoulos, G. A.,, I. N. Grivea,, N. G. Beratis,, A. E. Spiliopoulou,, E. L. Fasola,, S. Bajaksouzian,, P. C. Appelbaum, and, M. R. Jacobs. 1997. Resistance patterns of Streptococcus pneumoniae from carriers attending day-care centers in southwestern Greece. Clin. Infect. Dis. 25: 188194.
90. Syrogiannopoulos, G. A.,, I. N. Grivea,, A. Tait-Kamradt,, G. D. Katopodis,, N. G. Beratis,, J. Sutcliffe,, P. C. Appelbaum, and, T. A. Davies. 2001. Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece. Antimicrob. Agents Chemother. 45: 342344.
91. Talbot, T. R.,, K. A. Poehling,, T. V. Hartert,, P. G. Arbogast,, N. B. Halasa,, E. Mitchel,, W. Schaffner,, A. S. Craig,, K. M. Edwards, and, M. R. Griffin. 2004. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin. Infect. Dis. 39: 641648.
92. Temime, L.,, P. Y. Boelle,, A. J. Valleron, and, D. Guillemot. 2005. Penicillin-resistant pneumococcal meningitis: high antibiotic exposure impedes new vaccine protection. Epidemiol. Infect. 133: 493501.
93. Temime, L.,, D. Guillemot, and, P. Y. Boelle. 2004. Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrob. Agents Chemother. 48: 22062213.
94. Tempest, B.,, J. P. Carney, and, B. Eberle. 1974. Distribution of the sensitivities to penicillin of types of Diplococcus pneumoniae in an American Indian population. J. Infect. Dis. 130: 6769.
95. Toltzis, P.,, M. Dul,, M. A. O'Riordan,, M. R. Jacobs, and, J. Blumer. 2006. Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city. Pediatr. Infect. Dis. J. 25: 1924.
96. Ussery, X. T.,, B. D. Gessner,, H. Lipman,, J. A. Elliott,, M. J. Crain,, P. C. Tien,, A. J. Parkinson,, M. Davidson,, R. R. Facklam, and, R. F. Breiman. 1996. Risk factors for nasopharyngeal carriage of resistant Streptococcus pneumoniae and detection of a multiply resistant clone among children living in the Yukon-Kuskokwim Delta region of Alaska. Pediatr. Infect. Dis. J. 15: 986992.
97. Vanderkooi, O. G.,, D. E. Low,, K. Green,, J. E. Powis, and, A. McGeer. 2005. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin. Infect. Dis. 40: 12881297.
98. Whitney, C. G.,, M. M. Farley,, J. Hadler,, L. H. Harrison,, C. Lexau,, A. Reingold,, L. Lefkowitz,, P. R. Cieslak,, M. Cetron,, E. R. Zell,, J. H. Jorgensen, and, A. Schuchat. 2000. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343: 19171924.
99. Whitney, C. G.,, T. Pilishvili,, M. M. Farley,, W. Schaffner,, A. S. Craig,, R. Lynfield,, A. C. Nyquist,, K. A. Gershman,, M. Vazquez,, N. M. Bennett,, A. Reingold,, A. Thomas,, M. P. Glode,, E. R. Zell,, J. H. Jorgensen,, B. Beall, and, A. Schuchat. 2006. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368: 14951502.
100. Widdowson, C. A.,, P. V. Adrian, and, K. P. Klugman. 2000. Acquisition of chloramphenicol resistance by the linearization and integration of the entire staphylococcal plasmid pC194 into the chromosome of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44: 393395.
101. Widdowson, C. A., and, K. P. Klugman. 1999. Molecular mechanisms of resistance to commonly used non-beta-lactam drugs in Streptococcus pneumoniae. Semin. Respir. Infect. 14: 255268.
102. Widdowson, C. A.,, K. P. Klugman, and, D. Hanslo. 1996. Identification of the tetracycline resistance gene, tet(O), in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40: 28912893.
103. Yagupsky, P.,, N. Porat,, D. Fraser,, F. Prajgrod,, M. Merires,, L. McGee,, K. P. Klugman, and, R. Dagan. 1998. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J. Infect. Dis. 177: 10031012.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error